Sapphiros AI Bio LLC announced that it has raised $30 million in a round of funding led by new investor, OraSure Technologies, Inc. on January 4, 2024. The company issued common shares in the transaction. As a part of transaction, the investor became the part of board of the company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.025 USD | -0.12% |
|
-5.05% | -50.67% |
Jun. 24 | OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from S&P 600 Health Care | CI |
Jun. 24 | OraSure Technologies, Inc.(NasdaqGS:OSUR) dropped from S&P 1000 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.67% | 298M | |
-7.46% | 178B | |
-6.77% | 98.95B | |
-7.13% | 66.14B | |
-9.97% | 44.11B | |
+6.82% | 43.82B | |
+10.10% | 42.74B | |
+11.25% | 28.92B | |
+18.89% | 25.06B | |
-8.63% | 23.38B |
- Stock Market
- Equities
- OSUR Stock
- News OraSure Technologies, Inc.
- Sapphiros AI Bio LLC announced that it has received $30 million in funding from OraSure Technologies, Inc.